Aaron Lorenzo

Blood substitute developer Northfield Laboratories Inc. topped off the tank with $15 million in financing to fund a pivotal trial of its lead product, PolyHeme. (BioWorld Today)

Northfield To Support PolyHeme Pivotal Trial With $15M Financing

Jan. 27, 2004

By Aaron Lorenzo

Blood substitute developer Northfield Laboratories Inc. topped off the tank with $15 million in financing to fund a pivotal trial of its lead product, PolyHeme. (BioWorld Today)

AEterna, Zentaris Enter Another LHRH Product Deal With Solvay

Jan. 26, 2004

By Aaron Lorenzo

Aaron Lorenzo

ARTICLES

Palatin Raises $22.7M For Drug Trials Via Stock, Warrants Sale

Chiron Earnings Rise Due To Vaccine, Other Product Growth

Chiron Earnings Rise Due To Vaccine, Other Product Growth

Genelabs Licenses Out Japanese Prestara Rights For Up To $12M

Genelabs Licenses Out Japanese Prestara Rights For Up To $12M

Sirna Agrees To RNAi Cancer Drug Collaboration With Lilly

Sirna Agrees To RNAi Cancer Drug Collaboration With Lilly

Northfield To Support PolyHeme Pivotal Trial With $15M Financing

Northfield To Support PolyHeme Pivotal Trial With $15M Financing

AEterna, Zentaris Enter Another LHRH Product Deal With Solvay

Today's news in brief

Cas and effect: Merck’s phase III ripples HIF-2α space

News in brief

Brain’s hidden tau-clearing pathway uncovered

Anticancer drug exerts potent HIV antiviral effects